Thus, kidney disease in AASK participants was strongly associated with APOL1 renal risk variants.

The required label revisions include monitoring of renal function and cautionary language regarding the use of telavancin in patients with certain renal risk factors.

Several drugs used in the treatment of type 2 diabetes are associated with pleiotropic effects that could favourably or unfavourably change patients' renal risk profile.

Context: Diabetes insipidus (DI) is rare in the neonatal period but of great importance due to increased renal risk and mental retardation despite treatment.

Objective: Lithium is an important mood disorder treatment; however, the renal risks of its use in older adults are unclear.